Neurobiology of Disease

Article	Citations
The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier	308
Genetics of Parkinson's disease: An introspection of its journey towards precision medicine	229
Microglia and astrocyte dysfunction in parkinson's disease	171
The microbiota-immune axis as a central mediator of gut-brain communication	106
Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation	105
Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis	99
Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease	97
How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synucle	91
Long-lasting blood-brain barrier dysfunction and neuroinflammation after traumatic brain injury	88
Mitochondrial fission in Huntington's disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca2+ efflux and Reactive Oxygen Species (ROS) homeostasis	84
APOE in the normal brain	80
Passive immunotherapies targeting Aβ and tau in Alzheimer's disease	77
Microglia reprogram metabolic profiles for phenotype and function changes in central nervous system	76
Fragile X syndrome and associated disorders: Clinical aspects and pathology	74
Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies	73
Plasmalogens, platelet-activating factor and beyond – Ether lipids in signaling and neurodegeneration	72
Genetic architecture of Alzheimer's disease	72
Neuropathological evidence of body-first vs. brain-first Lewy body disease	69
The wrinkling of time: Aging, inflammation, oxidative stress, and the circadian clock in neurodegeneration	69
Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports	68
Beyond the CNS: The many peripheral roles of APOE	65
Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease	65
CRISPR/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model mice	65
APOE-amyloid interaction: Therapeutic targets	62
INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia	62

Oligomeric α-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease	61
APOE alters glucose flux through central carbon pathways in astrocytes	61
Shifting paradigms: The central role of microglia in Alzheimer's disease	58
It's complicated: The relationship between sleep and Alzheimer's disease in humans	58
Obstructive Sleep Apnea and Its Treatment in Aging: Effects on Alzheimer’s disease Biomarkers, Cognition, Brain Structure and Neurophysiology	56
Glia: victims or villains of the aging brain?	55
The contribution of glial cells to Huntington's disease pathogenesis	54
Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice	53
Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons	52
Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration	52
Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response	52
TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia	52
Clinical and imaging evidence of brain-first and body-first Parkinson's disease	51
Immunotherapy for Parkinson’s disease	51
An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington's disease	51
Cilia, ciliopathies and hedgehog-related forebrain developmental disorders	50
Glia in neurodegeneration: Drivers of disease or along for the ride?	50
Roles of lysosomotropic agents on LRRK2 activation and Rab10 phosphorylation	49
Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer's disease	48
Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study	48
Defining molecular identity and fates of CNS-border associated macrophages after ischemic stroke in rodents and humans	48
The genetic architecture of ALS	48
Single-cell RNA-seq analysis of the brainstem of mutant SOD1 mice reveals perturbed cell types and pathways of amyotrophic lateral sclerosis	47
Beta-adrenergic receptor antagonism is proinflammatory and exacerbates neuroinflammation in a mouse model of Alzheimer's Disease	47
Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease	46
Multielectrode array analysis of EEG biomarkers in a mouse model of Fragile X Syndrome	46
Local field potentials in Parkinson's disease: A frequency-based review	45
SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein	44
Local field potential activity dynamics in response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease	44
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome	44
Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD	44
Primary motor cortex in Parkinson’s disease: Functional changes and opportunities for neurostimulation	43
Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How	43
Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer's disease	42
Mechanosensation in traumatic brain injury	41
Neurostimulation techniques to enhance sleep and improve cognition in aging	41
Soluble TREM2: Innocent bystander or active player in neurological diseases?	41
Disruption of endoplasmic reticulum-mitochondria tethering proteins in post-mortem Alzheimer's disease brain	39
Curcumin attenuates cognitive impairment by enhancing autophagy in chemotherapy	39
What are activated and reactive glia and what is their role in neurodegeneration?	39
Indoles as essential mediators in the gut-brain axis. Their role in Alzheimer's disease	39
Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia	39
Small RNA modifications in Alzheimer's disease	38
The projections from the anterior cingulate cortex to the nucleus accumbens and ventral tegmental area contribute to neuropathic pain-evoked aversion in rats	38
Primary cilia and ciliary signaling pathways in aging and age-related brain disorders	37
Sustained neuronal and microglial alterations are associated with diverse neurobehavioral dysfunction long after experimental brain injury	36
Regulatory T cells promote remyelination in the murine experimental autoimmune encephalomyelitis model of multiple sclerosis following human neural stem cell transplant	36
PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats	36
Glial cells involvement in spinal muscular atrophy: Could SMA be a neuroinflammatory disease?	35
The association of epigenetic clocks in brain tissue with brain pathologies and common aging phenotypes	35

Simultaneous mass spectrometry imaging of multiple neuropeptides in the brain and alterations induced by experimental parkinsonism and L-DOPA therapy	35
The drug adaptaquin blocks ATF4/CHOP-dependent pro-death Trib3 induction and protects in cellular and mouse models of Parkinson's disease	35
Bone marrow mesenchymal stem cells upregulate PI3K/AKT pathway and down-regulate NF-κB pathway by secreting glial cell-derived neurotrophic factors to regulate microglial polarization and alleviate de	35
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo	34
Translational opportunities in the prenatal immune environment: Promises and limitations of the maternal immune activation model	34
Pleiotropic effects of BDNF on the cerebellum and hippocampus: Implications for neurodevelopmental disorders	34
Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments	34
Animal models of brain-first and body-first Parkinson's disease	34
Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series	34
Genome-wide microRNA profiling of plasma from three different animal models identifies biomarkers of temporal lobe epilepsy	33
Differential roles of pyramidal and fast-spiking, GABAergic neurons in the control of glioma cell proliferation	33
REM sleep behavior disorder (RBD)	33
Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism	33
Characterization of tau binding by gosuranemab	33
ApoE and cerebral insulin: Trafficking, receptors, and resistance	32
Somatic mutations in neurodegeneration: An update	32
Neurobiology of coronaviruses: Potential relevance for COVID-19	32
Impact of sleep disturbances on neurodegeneration: Insight from studies in animal models	32
PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia	32
Effects of exercise on sleep in neurodegenerative disease	31
Advances in protein-protein interaction network analysis for Parkinson's disease	31
RNA-mediated toxicity in C9orf72 ALS and FTD	31
N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity	31
Inactivation of Hippo and cJun-N-terminal Kinase (JNK) signaling mitigate FUS mediated neurodegeneration in vivo	31
Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model	31
Developmental alterations in firing properties of hippocampal CA1 inhibitory and excitatory neurons in a mouse model of Dravet syndrome	31
The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis	30
Disruption of the sodium-dependent citrate transporter SLC13A5 in mice causes alterations in brain citrate levels and neuronal network excitability in the hippocampus	30
Glucocorticoid impairs mitochondrial quality control in neurons	30
Molecular chaperones and Parkinson's disease	30
(R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: A role of gut–microbiota–brain axis	30
Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC) -derived sensory neurons	30
Polygenic risk and pleiotropy in neurodegenerative diseases	30
The epitranscriptome in stem cell biology and neural development	30
The three-phase enriched environment paradigm promotes neurovascular restorative and prevents learning impairment after ischemic stroke in rats	30
Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's disease	29
Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease	29
Expansion microscopy: A powerful nanoscale imaging tool for neuroscientists	29
Tau-mediated dysregulation of RNA: Evidence for a common molecular mechanism of toxicity in frontotemporal dementia and other tauopathies	29
Directional deep brain stimulation leads reveal spatially distinct oscillatory activity in the globus pallidus internus of Parkinson's disease patients	29
Protein changes in synaptosomes of Huntington's disease knock-in mice are dependent on age and brain region	29
Analysis of homozygous and heterozygous Csf1r knockout in the rat as a model for understanding microglial function in brain development and the impacts of human CSF1R mutations	29
Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine	29
Immune responses in the Parkinson's disease brain	28
An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress	28
Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function	28
Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer's patients	28
Robust chronic convulsive seizures, high frequency oscillations, and human seizure onset patterns in an intrahippocampal kainic acid model in mice	28
Amyloid beta acts synergistically as a pro-inflammatory cytokine	28
Characterization of novel conformation-selective α-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease	28
The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease	28
Glial-neuron crosstalk in health and disease: A focus on metabolism, obesity, and cognitive impairment	27
Delayed administration of the human anti-RGMa monoclonal antibody elezanumab promotes functional recovery including spontaneous voiding after spinal cord injury in rats	27
Striatal synaptic adaptations in Parkinson's disease	27
Schwann cell functions in peripheral nerve development and repair	27
A homozygous MRPL24 mutation causes a complex movement disorder and affects the mitoribosome assembly	27
Behavioral, axonal, and proteomic alterations following repeated mild traumatic brain injury: Novel insights using a clinically relevant rat model	27
Sequential screening nominates the Parkinson's disease associated kinase LRRK2 as a regulator of Clathrin-mediated endocytosis	27
Circadian alterations in patients with neurodegenerative diseases: Neuropathological basis of underlying network mechanisms	26
Why Woody got the blues: The neurobiology of depression in Huntington's disease	26
Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments	26
Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease	26
Genetic architecture of common non-Alzheimer’s disease dementias	26
Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration	26
Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2	26
Neuron-astrocyte transmitophagy is altered in Alzheimer's disease	25
The role of glia in protein aggregation	25
Neuron-specific Kv1.1 deficiency is sufficient to cause epilepsy, premature death, and cardiorespiratory dysregulation	25
Inflammation in dementia with Lewy bodies	25
Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex	25
Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome	25
Cerebral small vessel disease alters neurovascular unit regulation of microcirculation integrity involved in vascular cognitive impairment	24
Striatal glutamatergic hyperactivity in Parkinson's disease	24
FMRP regulates presynaptic localization of neuronal voltage gated calcium channels	24
The role of Alzheimer's disease risk genes in endolysosomal pathways	24
Developmental exposure to the organochlorine pesticide dieldrin causes male-specific exacerbation of α-synuclein-preformed fibril-induced toxicity and motor deficits	24
Extracellular vesicles in the treatment of neurological disorders	24
Subthalamic deep brain stimulation induces finely-tuned gamma oscillations in the absence of levodopa	24
Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathology	24
Ceramide signalling in inherited and multifactorial brain metabolic diseases	23

Genetic testing for neurodegenerative diseases: Ethical and health communication challenges	23
Beneficial effects of the phytocannabinoid Δ9-THCV in L-DOPA-induced dyskinesia in Parkinson's disease	23
Super-resolution STED microscopy in live brain tissue	23
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders	23
Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer’s disease (AD) risk	23
ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease	23
Gallic acid attenuates blood-spinal cord barrier disruption by inhibiting Jmjd3 expression and activation after spinal cord injury	23
ALS and Parkinson's disease genes CHCHD10 and CHCHD2 modify synaptic transcriptomes in human iPSC-derived motor neurons	23
Vitamin E prevents lipid peroxidation and iron accumulation in PLA2G6-Associated Neurodegeneration	23
APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease	23
Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis	23
STED and parallelized RESOLFT optical nanoscopy of the tubular endoplasmic reticulum and its mitochondrial contacts in neuronal cells	22
Modeling UBQLN2-mediated neurodegenerative disease in mice: Shared and divergent properties of wild type and mutant UBQLN2 in phase separation, subcellular localization, altered proteostasis pathways,	22
The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo	22
Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis	22
Traumatic brain injury in women across lifespan	22
Influence of metabolic syndrome on cerebral perfusion and cognition	22
Acute knockdown of Depdc5 leads to synaptic defects in mTOR-related epileptogenesis	22
Suppression of glycogen synthesis as a treatment for Lafora disease: Establishing the window of opportunity	22
Leptin enhances adult neurogenesis and reduces pathological features in a transgenic mouse model of Alzheimer’s disease	22
Regulation of neuronal autophagy and the implications in neurodegenerative diseases	22
Early cerebrovascular and long-term neurological modifications ensue following juvenile mild traumatic brain injury in male mice	22
Near-infrared nanoscopy with carbon-based nanoparticles for the exploration of the brain extracellular space	22
Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis	22
Abnormal patterns of sleep and EEG power distribution during non-rapid eye movement sleep in the sheep model of Huntington's disease	21
Every-other-day feeding exacerbates inflammation and neuronal deficits in 5XFAD mouse model of Alzheimer's disease	21
Eight cylindrical contact lead recordings in the subthalamic region localize beta oscillations source to the dorsal STN	21
X-linked cellular mosaicism underlies age-dependent occurrence of seizure-like events in mouse models of CDKL5 deficiency disorder	21
MCT2 overexpression rescues metabolic vulnerability and protects retinal ganglion cells in two models of glaucoma	21
Synaptic pathology in Huntington's disease: Beyond the corticostriatal pathway	21
Nanoparticle encapsulated oxytocin increases resistance to induced seizures and restores social behavior in Scn1a-derived epilepsy	21
Dopamine D1-D2 receptor heteromer expression in key brain regions of rat and higher species: Upregulation in rat striatum after cocaine administration	21
Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson's disease	21
Muscle fiber-type specific terminal Schwann cell pathology leads to sprouting deficits following partial denervation in SOD1G93A mice	21
Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression	20
Striatal glutamate delta-1 receptor regulates behavioral flexibility and thalamostriatal connectivity	20
Exposure to anti-seizure medications impact growth of gut bacterial species and subsequent host response	20
Detrimental impacts of mixed-ion radiation on nervous system function	20
Ethanol-mediated alterations in oligodendrocyte differentiation in the developing brain	20
Altered excitatory transmission onto hippocampal interneurons in the IQSEC2 mouse model of X-linked neurodevelopmental disease	19
Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury	19
Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity	19
Epigenetic principles underlying epileptogenesis and epilepsy syndromes	19
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate	19
Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms	19
Spatial and temporal profile of high-frequency oscillations in posttraumatic epileptogenesis	19
HuD regulates SOD1 expression during oxidative stress in differentiated neuroblastoma cells and sporadic ALS motor cortex	19
Facemasks and face recognition: Potential impact on synaptic plasticity	19
To target Tau pathologies, we must embrace and reconstruct their complexities	19
APOE4 confers transcriptomic and functional alterations to primary mouse microglia	19
MANF is neuroprotective against ethanol-induced neurodegeneration through ameliorating ER stress	19
Epigenetic regulators of neuronal ferroptosis identify novel therapeutics for neurological diseases: HDACs, transglutaminases, and HIF prolyl hydroxylases	19
Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage	19
Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy	19
Delayed administration of high dose human immunoglobulin G enhances recovery after traumatic cervical spinal cord injury by modulation of neuroinflammation and protection of the blood spinal cord barr	19
Directing LRRK2 to membranes of the endolysosomal pathway triggers RAB phosphorylation and JIP4 recruitment	18
Genuine high-order interactions in brain networks and neurodegeneration	18
Neuron-specific mitochondrial oxidative stress results in epilepsy, glucose dysregulation and a striking astrocyte response	18
Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanisms	18
Dysregulation of Rac or Rho elicits death of motor neurons and activation of these GTPases is altered in the G93A mutant hSOD1 mouse model of amyotrophic lateral sclerosis	18
Molecular mechanisms of psychiatric diseases	18
HIV and opiates dysregulate K+- Cl− cotransporter 2 (KCC2) to cause GABAergic dysfunction in primary human neurons and Tat-transgenic mice	18
ALS-linked cytoplasmic FUS assemblies are compositionally different from physiological stress granules and sequester hnRNPA3, a novel modifier of FUS toxicity	18
Knockdown of GADD34 in neonatal mutant SOD1 mice ameliorates ALS	18
Inclusion of African American/Black adults in a pilot brain proteomics study of Alzheimer's disease	18
Overlaps, gaps, and complexities of mouse models of Developmental and Epileptic Encephalopathy	18
Melatonin treatment of repetitive behavioral deficits in the Cntnap2 mouse model of autism spectrum disorder	18
Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials	18
Gait variability is linked to the atrophy of the Nucleus Basalis of Meynert and is resistant to STN DBS in Parkinson's disease	18
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition	18
The silence of the fats: A MAM’s story about Alzheimer	18
Diagnostic and prognostic values of PBMC proteins in amyotrophic lateral sclerosis	18
Dynamic functional connectivity and graph theory metrics in a rat model of temporal lobe epilepsy reveal a preference for brain states with a lower functional connectivity, segregation and integration	18
Neuroimaging and neuropathology studies of X-linked dystonia parkinsonism	18
Bacterial sepsis increases hippocampal fibrillar amyloid plaque load and neuroinflammation in a mouse model of Alzheimer's disease	18
Type I interferon response-related microglial Mef2c deregulation at the onset of Alzheimer's pathology in 5×FAD mice	18
NADPH oxidase 2 activity in Parkinson's disease	18
Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection	18
Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis	18
The evolution of dystonia-like movements in TOR1A rats after transient nerve injury is accompanied by dopaminergic dysregulation and abnormal oscillatory activity of a central motor network	18
In vivo aggregation of presynaptic alpha-synuclein is not influenced by its phosphorylation at serine-129	17
MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia	17
Gut microbiome effects on neuronal excitability & activity: Implications for epilepsy	17
Dystonia 16 (DYT16) mutations in PACT cause dysregulated PKR activation and eIF2α signaling leading to a compromised stress response	17
VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology	17
Gene expression in the epileptic (EL) mouse hippocampus	17
Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice	17
Brain edema formation and therapy after intracerebral hemorrhage	17
GDNF signaling in subjects with minimal motor deficits and Parkinson's disease	17
Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons	17
DNA damage and repair following traumatic brain injury	17
Four-month treadmill exercise prevents the decline in spatial learning and memory abilities and the loss of spinophilin-immunoreactive puncta in the hippocampus of APP/PS1 transgenic mice	17
Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status	17
Striatal Synaptic Dysfunction in Dystonia and Levodopa-Induced Dyskinesia	17
Inflammatory and neurodegenerative pathophysiology implicated in postpartum depression	17